20328 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles
Amorphous solid dispersions of dasatinib and uses thereof
#302METHODS OF TREATING TYROSINE KINASE INHIBITOR-INDUCED DIARRHEA
#303Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
#304TREATMENT OF MALIGNANCIES
#305Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
#306LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR
#307TMA-formation inhibitor treatment for elevated TMA-containing compound diseases
#308PRESERVATIVE CONTAINING COMPOSITIONS
#309Animal treatments
#310FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
#311TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION
#312SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OF A SEDATIVE DRUG AND USES THEREOF
#313ANTIMICROBIAL DRUG SYNTHESIS AND THERAPEUTIC COMPOSITIONS
#314COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS
#315COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
#316COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM
#317ANTI-VIRAL COMPOSITIONS AND METHODS OF USE THEREOF
#318PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIEMETICS AND ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USING THE SAME FOR ANESTHESIOLOGICAL APPLICATIONS
#319SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR
#320Oral mucosal carrier and protectant
#321Synthetic Antibacterial Compounds and Uses Thereof
#322Arylazole compound and pest control agent
#323Compositions and methods for treating epilepsy and related disorders
#324Inhibitors for treatment of hematological malignancies
#325DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT
#326PETROLATUM-BASED COMPOSITIONS AND METHODS OF TREATMENT FOR ONYCHOMYCOSIS
#327Vaginal gel
#328PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
#329Bisphenol derivatives and their use as androgen receptor activity modulators
#330Method for treating nasal, sinonasal, and nasopharyngeal tissue infection and/or inflammation
#331Oxymetazoline compositions
#332PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#333ANTIMICROBIAL DRUG METHODS OF USE & THERAPEUTIC COMPOSITIONS
#334Thioureylene liquid compositions
#335Methods and compositions for treatment of glaucoma and related conditions
#336ENCAPSULATED CELLS PRODUCING CYTOCHROME P450 AND METHODS OF USE THEREOF
#337BIOACTIVE VITAMIN COMBINATIONS
#338SOLID DISPERSION OF RIFAMYCIN-NITROIMIDAZOLE COUPLING MOLECULE AND APPLICATION THEREOF
#339Treatment of rhinosinusitis with p-glycoprotein inhibitors
#340Compounds, compositions, and methods for the treatment and prevention of avian pathogenic (APEC)
#341WOUND PREVENTION AND/OR TREATMENT AND RELATED COMPOUNDS, MATRICES, COMPOSITIONS, METHODS AND SYSTEMS
#342Compositions for treating CMT and related disorders
#343Composition for increasing sexual desire or pleasure
#344Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
#345SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#346Compositions and methods for treating Crohn's Disease and related conditions and infections
#347SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#348SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#349Systems, methods, and kits for diagnostics and treatment of viral respiratory infection
#350Coordinated metabolic reprogramming in response to productive viral infections
#351METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY
#352Compositions for oral cancer or an oropharyngeal cancer
#353COMPOUNDS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND METHODS THEREOF
#354Secnidazole for use in the treatment of bacterial vaginosis
#355Hepatitis B antiviral agents
#356Drug-Eluting Spacer for Joints of the Human Body
#357Bacteriocins to improve vaginal colonization of hydrogen peroxide producing lactobacillus for female reproductive health
#358Methods of treating hepatic encephalopathy
#359Heterocyclic sulfonamide derivatives and pharmaceutical uses thereof
#360MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#361LIVER X RECEPTOR (LXR) MODULATORS
#362COMPOSITION CONTAINING BECLOMETHASONE FOR THE PREVENTION AND THE TREATMENT OF BACTERIAL PROSTATITIS AND VAGINITIS
#363Secnidazole for use in the treatment of sexually transmitted infection
#364Melanocortin agents for use in the therapeutic treatment of melanoma, tumors of the gastrointestinal tract, and thyroid carcinoma
#365Methods of using androgen receptor inhibitors as cancer therapeutics
#366BTNL3/8 targeting constructs for delivery of payloads
#367Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response
#368Amorphous solid dispersions of dasatinib and uses thereof
#369COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#370Hepatitis B antiviral agents
#371PATHOGEN CONTROL COMPOSITIONS AND USES THEREOF
#372Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy
#373TOPICAL DETOMIDINE FORMULATIONS
#374Nitroimidazole formulations
#375Treatment and diagnosis of melanoma
#376Suspensions and diluents for metronidazole and baclofen
#377Compositions and methods for treating ocular disorders
#378Glucono delta-lactone for treatment of vaginal fungal infections
#379DETERRENTS FOR ARTHROPODS AND MARINE ORGANISMS
#380INJECTABLE THERMORESPONSIVE HYDROGELS AS A COMBINATORY MODALITY FOR CONTROLLED DRUG DELIVERY, BIOMATERIAL IMPLANT AND 3D PRINTING BIOINK
#381Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation
#382MODULATORS OF THE INTEGRATED STRESS PATHWAY
#383Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors
#384TREATMENT OF VIRAL INFECTIONS AND VIRALLY ASSOCIATED LESIONS WITH SEQUITERPENE LACTONES
#385Treating and preventing disease with TMA and TMAO lowering agents
#386TARGETED DELIVERY OF HYDROPHILIC DRUGS TO LUNG
#387Treatment of Inflammatory Lesions of Rosacea with Ivermectin
#388COMBINATION PHARMACEUTICAL, PROPHYLACTIC OR SUPPRESSIVE AGENT FOR DEVELOPMENT OF RESISTANCE TO PYRIMIDINE ANTIMETABOLITE, AND METHOD OF TREATING DISEASE
#389Platform drug delivery system utilizing crystal engineering and theanine dissolution
#390Systems and devices for delivering fluids to the eye and methods of use
#391Stabilized oxymetazoline formulations and their uses
#392Novel class of compounds for the treatment of cardiovascular disease.
#393Vaginal hydrogel for delivery of therapeutics
#394Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
#395COMPOSITIONS AND METHODS FOR TREATING CANCER
#396Selective androgen receptor degrader (SARD) ligands and methods of use
#397ANTIBIOTIC GEL FORMULATION AND METHODS OF PREPARING THE ANTIBIOTIC GEL FORMULATION
#398Spirolactone compounds
#399Hot melt extrusion for pharmaceutical vaginal film products
#400METHODS OF TREATING PEDIATRIC PATIENTS USING DEXMEDETOMIDINE
#401Oxymetazoline compositions
#402NOVEL COMBINATION PRODUCT
#403Inhibitors of metallo-beta-lactamases
#404USE OF GLUCOCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#405Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
#4062- or 3-imidazolines as carbapenemases inhibitors
#407GLUCOCORTICOID RECEPTOR MODULATORS
#408METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#409METHODS FOR TREATING NEUROLOGICAL DISORDERS WITH a1A-AR PARTIAL AGONISTS
#410Methods for treating neurological disorders with α-AR partial agonists
#411COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO
#412Pharmaceutical composition comprising eluxadoline, process of preparation and use thereof
#413Liquid oral pharmaceutical dosage form
#414METAL OXIDE AND POLYMER-CONTROLLED DELIVERY SYSTEMS, SUNSCREENS, TREATMENTS, AND TOPICAL COATING APPLICATORS FOR ANTIFUNGAL AND ANTIMICROBIAL AGENTS
#415Diiodohydroxyquinoline for the treatment of clostridium difficile infection
#416ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#417Compound to treat Sjogren's Syndrome
#418Modulation of oxidative stress and amino acid metabolism for the treatment or prevention of diseases and disorders
#419Compositions and methods for activating signaling through the CB1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin
#420COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#421METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB
#422L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB)
#423Substituted 6-membered aryl or heteroaryl allosteric modulators of nicotinic acetylcholine receptors
#424COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#425GALECTINS CONTROL MTOR IN RESPONSE TO ENDOMEMBRANE DAMAGE AND PROVIDE A MECHANISM AND TARGET FOR THE TREATMENT OF AUTOPHAGY-RELATED DISEASES
#426Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
#427METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#428Oral formulations of metronidazole and methods of treating an infection using same
#429COMPOSITIONS FOR ELIMINATING BACTERIAL PROMOTORS OF COLORECTAL CANCER BY INTRALUMINAL APPLICATION
#430Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
#431Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
#432OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISORDERS
#433DISEASE DETECTION AND TREATMENT BASED ON TRIMETHYL-LYSINE LEVELS
#434Intravaginal formulation
#435SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#436SURFACTANT-FREE, WATER-FREE FOAMABLE COMPOSITION AND BREAKABLE FOAMS AND THEIR USES
#437Oxymetazoline compositions
#438TOPICAL COMPOSITIONS
#439COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#440SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES
#441Compositions and methods for treating ocular disorders
#442SECNIDAZOLE SOFT GELATIN CAPSULE AND METHODS AND USES THEREOF
#443Methods for continuous manufacture of liposomal drug products
#444Kits and methods for assessing a condition or a risk of developing a condition, and related methods of treatment
#445COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS
#446Pharmaceutical compositions comprising silica microspheres
#447Patient treatment via teratogenic pharmaceutical compounds
#448Cancer diagnostic and treatment
#449Methods to control infection using new generation small molecule growth inhibitors
#450Thioureylene liquid compositions
#451METHOD OF TREATING HAND-FOOT SYNDROME AND SYMPTOMS ASSOCIATED THEREWITH
#452Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#453Prodrugs Activated by Reduction in the Cytosol
#454METHODS FOR TREATING DEPENDENCE
#455METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#456Compounds for inhibiting NS3 and compositions containing the inhibited protein
#457Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#458COMPOSITIONS AND METHODS FOR NON-SURGICAL TREATMENT OF PTOSIS
#459Antimicrobial drug synthesis and therapeutic compositions
#460Oxymetazoline compositions
#461Compositions and methods for combinatorial drug discovery in nanoliter droplets
#462Methods of increasing satellite cell proliferation with vorinostat or bosutinib
#463Topical analgesic compositions
#464Methods and compositions for increasing the potency of antifungal agents
#465Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#466COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A CORTICOSTEROID
#467Heterocyclic compounds for cancer imaging and treatment and methods for their use
#468METHODS FOR THE TREATMENT OF DEPRESSION
#469Imidazole-based compounds as hepatitis C virus inhibitors
#470Bisphenol derivatives and their use as androgen receptor activity modulators
#471Secnidazole for use in the treatment of trichomoniasis
#472Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#473Enteric combination therapy
#474Crystal form of PARP-1 inhibitor and preparation method therefor
#475Animal treatments
#476Secnidazole for use in the treatment of trichomoniasis
#477METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION
#478Combinations Of Lanosterol Or 25-Hydroxycholesterol Including Derivatives Thereof Useful In The Treatment Of Lens Disorders
#479Alpha keto acid compositions for treating hypo-albuminemia
#480Pharmaceutical cream compositions of oxymetazoline and methods of use
#481Kinase inhibitors
#482Methods of inhibiting kinases
#483Use of ALDH1A and agonist, catalyst and inhibitor thereof
#484DRUG TARGETING CANCER STEM CELL
#485DENTAL ANESTHETIC COMPRISING TETRACAINE AND A VASOCONSTRICTOR FOR INTRANASAL ADMINISTRATION
#486Methods for treating diseases or infections caused by or associated with using a halogenated salicylanilide
#487Topical tetracycline compositions
#488Methods of treating microbial infection and inflammation
#489Enhancement of cancer treatment efficiency via the sphingosine-1-phosphate pathway
#490COMBINATIONS FOR THE TREATMENT OF KIDNEY STONES
#491Salts and crystal forms of GABApositive allosteric modulator
#492SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
#493NASAL DECONGESTANT COMPOSITIONS COMPRISING DEXPANTHENOL AND SODIUM HYALURONATE
#494Compositions for treating CMT and related disorders
#495Treatment and diagnosis of melanoma
#496COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS BY CONTROLLING BLOOD GLUCOSE LEVEL
#497BIMODAL MODIFIED RELEASE COMPOSITIONS FOR CANCER TREATMENT
#498ANTI-FATIGUE COMPOSITION
#499Preservative containing compositions
#500Secnidazole for use in the treatment of bacterial vaginosis
#501Hepatitis B antiviral agents
#502Treatment of rhinosinusitis with P-glycoprotein inhibitors
#503Treating and preventing disease with TMA and TMAO lowering agents
#504COMPOSITIONS OF SCHISANDRA EXTRACTS AND METHODS THEREOF
#505Compounds and methods for inducing chondrogenesis
#506Compositions and methods for treating cancer
#507Antifungal compounds
#508METHODS FOR THE TREATMENT OF DEPRESSION
#509DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT
#510Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
#511COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
#512Methods for Accelerated Return of Skin Integrity and for the Treatment of Impetigo
#513COSMETIC AND PHARMACEUTICAL FOAM
#514Compositions and methods for inhibition of MICA/B shedding
#515Petrolatum-based compositions and methods of treatment for onychomycosis
#516Inhibitors of protease-activated receptor-2
#517Compositions against infections
#518COMPOUNDS AND METHODS FOR MODULATING FRATAXIN EXPRESSION
#519Solid Bar Shampoo
#520Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use thereof
#521Topical composition for treating rosacea and a method for treating rosacea with the same
#522Treating disease and promoting weight loss by inhibiting the TMA/FMO3/TMAO pathway
#523PHARMACEUTICAL AND FOOD COMPOSITION FOR THE TREATMENT OF VAGINAL AND INTESTINAL DYSBIOSIS
#524Methods and compositions for treatment of eye conditions
#525Methods of treating hepatic encephalopathy
#526COSMETIC AND PHARMACEUTICAL FOAM
#527Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
#528USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF ANAPHYLAXIS
#529Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity
#530Compositions and methods of modulating short-chain dehydrogenase
#531Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
#532Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#533Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
#534Crystalline form of Eluxadoline
#5352-(substituted benzene matrix) aromatic formate FTO inhibitor, preparation method therefor, and applications thereof
#536Treatment of a bacterial vaginal infection
#537Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
#538Salts and crystal forms of GABApositive allosteric modulator
#539DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF
#540Parasite therapy
#541COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM
#542Methods for inhibiting muscle atrophy
#543Topical compositions and methods of use thereof
#544FORMULATIONS OF ENZALUTAMIDE
#545ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA
#546Secnidazole for use in the treatment of bacterial vaginosis
#547Combination Therapy for Treating Cancer
#548Secnidazole for use in the treatment of bacterial vaginosis
#549Human genetic markers associated with response to treatments that target clostridium difficile toxin B
#550Topical tetracycline compositions
#551METHOD AND THERAPEUTIC/COSMETIC TOPICAL COMPOSITIONS FOR THE TREATMENT OF ROSACEA AND SKIN ERYTHEMA USING A1-ADRENOCEPTOR AGONISTS
#552Lactuloside compounds and preparation and use thereof
#553ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS
#554Compositions and methods for non-surgical treatment of ptosis
#555TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
#556Pharmaceutical compositions containing azaquinone for inhibiting clostridium difficile activity
#557Compositions and methods for the treatment and prevention of neurological disorders
#558Prosthetic tissue valves
#559ADMINISTRATION OF TAILORED FEEDSTOCK TO INCREASE ANTIBIOTIC SUSCEPTIBILITY
#560OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISORDERS
#561Methods and compositions to prevent or treat bacterial infections
#562ANTI-FATIGUE COMPOSITION
#563Compositions and methods for blocking sodium channels
#564Stabilized oxymetazoline formulations and their uses
#565COMPOSITIONS AND METHODS FOR LUNG REGENERATION
#566SYNERGISTIC ANTIMICROBIAL COMPOSITIONS
#567TOPICAL DETOMIDINE FORMULATIONS
#568MULTIPLE UNIT DOSAGE FORM COMPRISING A CORE WITH INDIVIDUAL CORE UNITS COVERED BY A MUCOADHESIVE MATERIAL AND AN ENTERIC CORE COATING
#569HOMOGENOUS FILM COMPOSITIONS
#570COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA
#571Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent
#572Body Cavity Foams
#573Vasoconstrictive and antibacterial combination treatment for rosacea
#574Medicinal vaginal lactobacillus cocktail
#575PHARMACEUTICAL COMPOSITIONS COMPRISING CLOFAZIMINE ANALOG COMPOUND B746 OR CLOFAZIMINE ANALOG COMPOUND B826
#576ADMINISTRATION OF TAILORED FEEDSTOCK TO INCREASE ANTIBIOTIC SUSCEPTIBILITY
#577Method of treating benign prostatic hyperlasia with antibiotics
#578Injectable implants
#579Deterrents for arthropods and marine organisms
#580Compositions and methods for treating clostridium difficile infection
#581NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME
#582Vaginal hydrogel for delivery of therapeutics
#583SUSPENSIONS AND DILUENTS FOR METRONIDAZOLE AND BACLOFEN
#584Compositions, gels and foams with rheology modulators and uses thereof
#585Methods for inhibiting infectious peritonitis
#586METHODS OF TREATING PEDIATRIC PATIENTS USING DEXMEDETOMIDINE
#587Topical tetracycline compositions
#588Compositions and methods of treating diabetic retinopathy
#589Secnidazole for use in the treatment of bacterial vaginosis
#590Transmammary delivery of cyclooxygenase-2 inhibitors for analgesia in neonates
#591Compositions and methods for treating Crohn's disease and related conditions and infections
#592Anti-PD-L1-anti-TIM-3 bispecific antibodies
#593Pharmaceutical compositions comprising silica microspheres
#594Trimethylamine-containing compounds for diagnosis and prediction of disease
#595Compositions, gels and foams with rheology modulators and uses thereof
#596COMPOSITIONS COMPRISING TIMOLOL AND AN ANTI-INFLAMMATORY AGENT
#597COMPOSITION FOR VAGINA AND ANTIMICROBIAL AGENT COMBINATION FOR USE IN PREPARING COMPOSITION FOR VAGINA
#598Compositions of Natural Extracts and Use Thereof in Methods for Preventing or Treating Diseases
#599Drug vehicle compositions and methods of use thereof
#600Composition for topical use based on a carnosine-magnesium complex